Medical News

RSS

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Techulon, Inc. announced today that its Glycofect Discovery and Therapeutic Delivery Platform has been awarded United States patent protection. The patented invention provides a new class of non-viral transfection vectors based on synthetic carbohydrate containing polyamides that can be used for both in vivo and in vitro applications.

16 May 2011

Teva signs definitive agreement to acquire Taiyo

Teva Pharmaceutical Industries Ltd. announced today that it has signed a definitive agreement to acquire 57% of the shares in privately-held Taiyo Pharmaceutical Industry Co. Ltd. for $460 million in cash paid to private shareholders.

16 May 2011

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced results from a Phase 2 clinical trial of OPC-34712, a novel D2 dopamine partial agonist investigational product.

16 May 2011

CDRD, University of Ottawa sign affiliation agreement for drug development platform

The University of Ottawa and the Centre for Drug Research and Development (CDRD) today announced that they have signed an affiliation agreement that will allow researchers at the University of Ottawa to access CDRD's drug development infrastructure and expertise.

16 May 2011

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.

16 May 2011

IRIN reports on temporary, free medical care in Cote d'Ivoire

"Many public hospitals in Cote d'Ivoire are overflowing as people rush to benefit from a brief period of free medical services, announced by the government [in April] as part of the recovery from months of post-election chaos. But the health ministry has been quick to point out that this is a temporary measure and fees will be reinstated at the end of May," IRIN writes in a story examining reaction to health care in the country.

16 May 2011

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

Researchers have linked a variant in the vitamin D receptor gene (VDR) with the onset of chronic obstructive pulmonary disease (COPD) in Caucasian men. The study population consisted of participants in the Veterans Administration Normative Aging Study, a multidisciplinary study of aging that began in 1963.

16 May 2011

State news: La. House passes abortion measure; Ga. faces sharp deficits in health plans; Calif. GOP offers budget plan

The House voted 96-0 for a bill that would require abortion providers to post additional information in public spaces; compel the state health agency to develop a new website on termination procedures; and alter the state's conscience protection clause that allows health-care professionals to opt out of certain tasks. Planned Parenthood, which provides reproductive counseling and services, including abortions at clinics located outside Louisiana, opposes House Bill 636 as intrusive and unnecessary.

16 May 2011

Insight into male infertility

Around one in 20 men is infertile, but despite the best efforts of scientists, in many cases the underlying causes of infertility have remained a mystery.

16 May 2011

Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patients

Vitamin D supplements may help patients with chronic obstructive pulmonary disease (COPD) get more from their pulmonary rehabilitation programs, according to a study conducted by researchers from Belgium.

16 May 2011

Hospital patients with pneumonia may face risk of sudden cardiac arrest

Hospital patients with pneumonia may be at risk of experiencing sudden cardiac arrest, often with few or no warning signs, according to research from the University of Chicago Medical Center under the auspices of the American Heart Association's Get with the Guidelines project.

16 May 2011

Obese men may face high risk of prostate cancer progression

Even when treated with hormone therapy to suppress tumor growth, obese men face an elevated risk of their prostate cancer worsening, researchers at Duke University Medical Center have found.

16 May 2011

Mylan introduces Cyclobenzaprine HCl ER Capsules, a muscle relaxant

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Cyclobenzaprine HCl ER Capsules and was awarded 180 days of marketing exclusivity.

16 May 2011

Viewpoints: Snappy headlines, prose on Romney and Medicare dominate Today's opinions and editorials

The first question he got from the audience after his speech Thursday was the right one: What's to prevent states from a "race to the bottom," where they cut their costs by slashing spending on health care? Romney had no good answer beyond a vague assertion that Americans are a "generous people" who would not deny health coverage to their fellow citizens.

16 May 2011

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

InterMune, Inc. today announced the publication of results from two Phase 3 trials demonstrating that treatment with pirfenidone, a novel antifibrotic and anti-inflammatory drug, was associated with favorable effects on lung function, 6-minute walk test distance and progression-free survival (PFS) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).

16 May 2011

Merck receives FDA approval for Victrelis to treat chronic hepatitis C

The U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who either have not been previously treated with drug therapy for their hepatitis C or who have failed such treatment.

16 May 2011

AIDS spread prevention by vaccine and anti HIV drugs

A latest vaccine against HIV/AIDS has shown to be effective in monkeys and has protected macaques the most widespread primate genus, against the monkey equivalent of HIV, Simian immunodeficiency virus (SIV). This could provide a fresh approach to an HIV vaccine, a study suggests. US researchers say the vaccine offered protection to 13 of 24 Rhesus macaques treated in the experiment. In 12 of the monkeys, the vaccine was still effective 12 months later.

15 May 2011

Immortality only appeals to 15% of people: Study

Results of a new ComRes opinion poll commissioned by Dying Matters, a coalition backed by several major charities which promotes discussion of end-of-life issues, shows that only 15% want to live forever.

15 May 2011

Genetic link for depression found: Study

Researchers have for the first time confirmed a specific genetic link to depression, according to new evidence published in the American Journal of Psychiatry on Monday. This finding was made independently by research teams in the UK and US, is expected to lead to a better biological understanding of the condition and eventually to more effective antidepressants.

15 May 2011

Tanning solariums exposing people to UV radiation six times the strength of midday sun: Study

According to the latest research, tanning sun beds can deliver wildly different doses of UV radiation, with some exposing users to levels up to six times the strength of the midday sun. Worst part of it that most users are unaware of this say experts. An audit of beds in Sydney and Melbourne found some deliver twice the dose of radiation as others classed in lower categories. The audits took place in Victoria and NSW.

15 May 2011

Medical News

Techulon receives U.S. patent protection for Glycofect Discovery and Therapeutic Delivery Platform

Teva signs definitive agreement to acquire Taiyo

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

CDRD, University of Ottawa sign affiliation agreement for drug development platform

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

IRIN reports on temporary, free medical care in Cote d'Ivoire

Study associates VDR gene variant with onset of chronic obstructive pulmonary disease in men

State news: La. House passes abortion measure; Ga. faces sharp deficits in health plans; Calif. GOP offers budget plan

Insight into male infertility

Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patients

Hospital patients with pneumonia may face risk of sudden cardiac arrest

Obese men may face high risk of prostate cancer progression

Mylan introduces Cyclobenzaprine HCl ER Capsules, a muscle relaxant

Viewpoints: Snappy headlines, prose on Romney and Medicare dominate Today's opinions and editorials

The Lancet publishes two pirfenidone Phase 3 trial results in idiopathic pulmonary fibrosis

Merck receives FDA approval for Victrelis to treat chronic hepatitis C

AIDS spread prevention by vaccine and anti HIV drugs

Immortality only appeals to 15% of people: Study

Genetic link for depression found: Study

Tanning solariums exposing people to UV radiation six times the strength of midday sun: Study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News